Summary This study compares the effect of y-linolenic acid (GLA) and its precursor linoleic acid (LA) on survival of 36B10 malignant rat astrocytoma cells and 'normal' rat astrocytes. GLA was cytotoxic to 36B10 cells but not to astrocytes. By contrast, LA supplementation did not affect the survival of either cell types. There were minor differences in the uptake, distribution and use of radiolabelled GLA and LA by the 36B1 0 cells and astrocytes. GLA and LA supplementation increased the total polyunsaturated fatty acid (PUFA) content of the cells indicating increased oxidative potential. However, elevated levels of 8-isoprostane, an indicator of increased oxidative stress, were only observed in the GLA supplemented 36B10 cells. Addition of the antioxidant trolox to GLA-enriched 36B10 cells blocked the cytotoxic effect. Further, GLA enhanced the radiation sensitivity of the astrocytoma cells but not the astrocytes; trolox blocked the GLA-mediated increase in astrocytoma cell radiosensitivity. LA did not affect the radiation response of either cell type. While cyclo-oxygenase inhibitors did not affect GLA cytotoxicity, they blocked the enhanced radiation response of GLA-supplemented cells. The lipoxygenase inhibitor NDGA did not affect the toxicity produced by GLA. Thus, GLA is toxic to the neoplastic astrocytoma cells but not to normal astrocytes.
Gamma linolenic acid (GLA, 18:3n6) supplementation has been reported to suppress the growth of tumour cells in vitro (Fujiwara et al, 1986; Sangeetha and Das, 1992; Falconer et al, 1994) and in vivo (Karmali et al, 1985; Abou et al, 1987) . Interestingly, in separate studies conducted on normal tissues in vivo, it has been reported that dietary GLA decreases the severity of radiation damage to the skin (Hopewell et al, 1993) and CNS (Hopewell et al, 1994) . We have previously shown that GLA supplementation can decrease clonogenic cell survival of malignant rat astrocytoma cells and increase their radiosensitivity (Vartak et al, 1997) . To determine the therapeutic potential of this observation, it is important to investigate the effect of GLA on 'normal' rat astrocytes. The purpose of this work was to compare the effects of GLA on the survival of 36B10 astrocytoma cells and astrocytes and their response to radiation. The uptake and use of GLA by astrocytoma cells has also been compared with that by astrocytes.
The cytotoxic action of polyunsaturated fatty acids (PUFAs) is thought to be mediated predominantly via lipid peroxidation and free radical generation (Begin et al, 1988; Ells et al, 1996) . Several studies also indicate that eicosanoid and leukotriene synthesis play an important role in tumour cell proliferation and metastasis (Earashi et al, 1995; Damtew and Spagnuolo, 1997) . Arachidonic acid (AA, 20:4n6) and dihomo-y-linolenic acid (DGLA, 20:3n6) are the substrate for the biosynthesis of prostaglandins of the 2-and 1-series respectively (Crawford, 1983) . GLA is metabolized to form DGLA and AA. Studies on the effect of PUFAs on eicosanoid synthesis have shown that GLA and other PUFAs increase prostanoid synthesis in cells (Bunce and Abou-El-Ela, 1990 ; Bell JG et al, 1995 , Rose et al, 1995 . In order to investigate the mechanism(s) by which GLA exerts a cytotoxic effect on astrocytoma cells, we have studied the role of lipid peroxidation and/or free radical generation, prostanoids and leukotrienes on the cytotoxic action of GLA and its enhancement of the response to radiation.
GLA is formed directly from linoleic acid (LA, 18:2n6) by the action of a delta 6-desaturase (Dunbar and Bailey, 1975) . Therefore, we have also investigated whether LA would produce effects similar to those obtained with GLA.
MATERIALS AND METHODS Cell and culture conditions
The tumour cell line tested was the ethylnitrosurea-induced 36B 10 malignant rat astrocytoma (Spence and Coates, 1978) . The 'normal' rat astrocytes used in the study were obtained as primary cell cultures isolated from 1-to 2-day-old Sprague-Dawley rat pups using the method of Murphy (1990) . Briefly, cortices were removed from the rat pups, meninges were stripped and the cortices homogenized. After incubation with trypsin for 15 min in a 37°C shaking water bath, the homogenate was centrifuged at room temperature for 2 min at 1000 r.p.m. The supematant was discarded and the pellet resuspended in a trypsin inhibitor/DNAase solution, triturated, layered over a bovine serum albumin (BSA) solution and centrifuged at room temperature for 7 min at 1000 r.p.m. The supernatant was removed and the pellet was resuspended in media. Cells were counted using a haemocytometer and plated at 56 000 cells cm-2.
Both cell types were incubated at 370C under a humidified atmosphere of 95% air:5% carbon dioxide. The astrocytoma cells were cultured in Dulbecco's modified Eagle medium containing 10% fetal bovine serum and L-glutamine (2 mM), penicillin (50 IU ml-') and streptomycin (50 jg ml-'). They were maintained as monolayer cultures in tissue culture flasks by routine passage. The astrocytes were cultured in Eagle's minimum essential medium containing 10% fetal bovine serum and 2 mM L-glutamine, 33 mM glucose and 60 ,ug ml-' gentamycin. All cell culture reagents were purchased from Gibco, Grand Island, NY, USA.
Cell survival analyses and cytotoxicity studies
The effect of GLA and LA, either alone or combined with radiation, on 36B10 astrocytoma cell survival (Cayman Chemical, Ann Arbor, MI, USA) was studied using the clonogenic cell survival assay. Viable cells assessed by the 0.4% erythrosin B dye exclusion method using a haemocytometer were seeded at varying densities depending on the radiation dose; 200 cells for unirradiated cells, 600 cells for 2.5 Gy, 1000 cells for 5 Gy, 1800 cells for 7.5 Gy and 2500 cells for 10 Gy (137Cs y-source; dose rate 1.5 Gy min-') in 60-mm dishes. At the end of a 7-day incubation period, they were stained with 0.1% crystal violet and the colonies (> 50 cells per colony) were counted using a dissecting microscope.
In order to study whether lipid peroxidation played a role in the effect of GLA on survival of 36B10 cells, 50 or 100 jM Trolox (Aldrich, Milwaukee, WI, USA) was added to the medium in addition to the GLA. Trolox is a water-soluble analogue of vitamin E and has been shown to protect mammalian cells from oxidative damage (Mickle et al, 1989; Wu et al, 1990) . Stock solutions of trolox (100 mM) were prepared in 1 M sodium bicarbonate as, at concentrations above 1.8 mm, trolox has poor solubility in water. The pH was adjusted to 7.0 using 1 N hydrochloric acid.
To investigate whether altered prostaglandin or leukotriene synthesis was involved in GLA cytotoxicity and/or the modified radiation response of GLA-supplemented cells, the cyclo-oxygenase inhibitors ibuprofen (50-100 jiM) or indomethacin (2.5-10 jM) and the lipoxygenase inhibitor nordihydroguaretic acid (NDGA, 1-5 jiM) were used. All inhibitors were added to the medium at the same time as GLA, and the cells were maintained in this medium throughout the experiment. Ibuprofen, indomethacin and NDGA were purchased from Sigma Chemical, St Louis, MO, USA.
Cell cytotoxicity studies for rat astrocytes As rat astrocytes do not form colonies, the effect of fatty acids on the survival of these cells was determined using the fluorescent dye Calcein AM (Molecular Probes, Eugene, OR, USA). In order to facilitate direct comparison between the effects of GLA and LA on the survival of astrocytes and astrocytoma cells, this assay was also performed using the 36B 10 cells.
Rat astrocytes (2500 cells per well) or astrocytoma cells (250 cells per well) were seeded onto 96-well plates. The two cell types were seeded at different densities because of the differences in their growth rates. The doubling time of rat astrocytes in culture is approximately 4 days, whereas that of the 36B 10 astrocytoma cells is 16 h (unpublished data). After an overnight incubation, the cells were supplemented with 30 or 45 jM GLA or LA and/or exposed to 2.5-10 Gy y-rays (1.5 Gy min-m; 137Cs y-source). The cells were then allowed to grow for 1-7 days at the end of which the viability of the cells was assessed. The cells were incubated with calcein-AM (live-cell fluorescence stain) at a final concentration of 1 jiM for 45 min at room temperature. The fluorescence then was measured using a fluorescence microplate reader (FL500, Bio-Tek Instruments, VI, USA). The live cell populations were characterized by an intense fluorescence in the 530-nm region.
Determination of 8-isoprostane levels
Astrocytoma cells and astrocytes were supplemented with 45 jM GLA or LA. The media was tested for 8-isoprostane 0-72 h after fatty acid supplementation. The isoprostanes are a family of eicosanoids of non-enzymatic origin produced through the random oxidation of tissue phospholipids by oxygen radicals. 8-Isoprostane (8-epiprostaglandin F2a) has been proposed as a marker of antioxidant deficiency and oxidative stress (Morrow et al, 1990 (Morrow et al, , 1992 . The level of 8-isoprostane after GLA and LA supplementation was measured using an EIA kit (Cayman Chemical). Briefly, the samples were incubated with the 8-isoprostane tracer (an 8-isoprostane-acetylcholinesterase conjugate) and 8-isoprostane polyclonal antiserum for 18 h at room temperature. After incubation, the plate was washed and developed for 60 min with Ellman's reagent (which contains the substrate for acetylcholinesterase). The plate was read at 405 nm using a microplate reader (CERESuv900c, Bio-Tek Instruments) and the amount of 8-isoprostane determined from an 8-isoprostane standard graph.
Incorporation of GLA and LA into cells Incorporation of GLA and LA into cells was determined after supplementation of the medium with 20 or 45 gM [1-14C] 18:3 or [1-14C] 18:2 for 1, 6, 24 and 48 h. Lipids were extracted from the cells using chloroform-methanol (2:1 v/v) following the standard protocol of Folch et al (1957) . The radiolabelled fatty acids present in the media were determined by separating the media from the cells after the required incubations using 20 gM [1-'4C] GLA or LA. To determine the amount of radioactivity remaining in the medium and the amount incorporated into the cells, aliquots were taken from the cell extract and from the medium, after it had been centrifuged at 2500 r.p.m. for 5 min to remove any cell debris. Lipids were extracted from the medium using two volumes of water saturated ethyl acetate. The ethyl acetate was removed by evaporation under nitrogen and the fatty acids separated by highperformance liquid chromatography (HPLC). The lipid extracts were then transesterified with 12% boron fluoride in methanol at 95°C for 45 min (Morrison and Smith, 1964) . The radiolabelled material was assayed using a liquid scintillation spectrophotometer (Packard Tricarb 4640). Quenching was monitored using an internal standard.
The phospholipid and neutral lipid fractions of the cell lipid extracts were separated by thin-layer chromatography (TLC) (Bell ME et al, 1982) . Neutral lipids were separated on Whatman silica gel G plates with a mixture of heptane-diethyl ether-acetic acidmethanol (90:20:2:3). Phospholipids were separated on Whatman LKSD plates with a mixture of chloroform-methanol-40% methanolamine (60:36:5). The distribution of radioactivity on the TLC plate was determined with a gas flow proportional scanner (Radiomatic model R). Lipid standards or radiolabelled standards were applied to each plate and the chromatogram was visualized under UV light after development by spraying with 1 mM 8-anilino-1-naphthalene sulphonic acid, or analysed using the radioisotope scanner.
To measure the conversion of the fatty acids to metabolites, the cell and medium lipid extracts were analysed by reverse-phase British Journal of Cancer (1998) HPLC (Gordon et al, 1994 0l. Distribution of GLA and LA in 36B130 astrocytoma cells and astrocytes
Using TLC it was determined that the majority of the total radiolabelled fatty acids taken up by the 36B10 cells and astrocytes supplemented with either fatty acids was present in the phospholipids. Figure 2 shows the distribution of [1-'4C] GLA into the different phospholipid classes of the astrocytoma cells ( Figure 2A ) and astrocytes ( Figure 2B ) between 1 and 48 h after GLA supplementation. The two cell types showed some differences in the distribution of the fatty acid in the various phospholipid classes. In the 36B10 cells, phosphatidylcholine (PC) contained approximately 60% of the radioactivity during the first 6 h. Subsequently, the amount of radioactivity in PC declined and phosphatidylethanolamine (PE) became the most heavily labelled fraction ( Figure 2A) . Thus, at 48 h, PE contained 60% of the radioactivity, with only 19% remaining in the PC. The amounts of phosphatidylinositol (PI) and phosphatidylserine (PS) also showed small increases with time. In the case of the astrocytes, however, PC contained most of the radioactivity at all the time points Figure 2B ). The amount of radioactivity in the remaining phospholipid classes showed small increases with time. Similar patterns of distribution were noticed when 36B10 cells and astrocytes were supplemented with LA (data not shown).
Metabolism of GLA and LA by 36B10 cells and astrocytes Figure 3 shows the conversion of [1-'4C] GLA to other radiolabelled fatty acids by the 36B 10 cells and astrocytes. The 36B 10 cells rapidly converted GLA to DGLA and AA; by 24 h, all of the [1-'4C] GLA supplied was metabolized mainly to AA ( Figure 3A) . On the other hand, the astrocytes quickly converted the GLA to DGLA, AA and docosatetraenoic acid (DTA, 22:4n6; Figure 3B ). As in the case of the 36B10 cells, AA was the predominant product in the astrocytes from 6 to 48 h GLA supplementation. Effect of GLA and LA on the survival and radiation response of 36B10 cells and rat astrocytes Figure SA and B show the effect of LA or GLA supplementation on the survival and the radiation response of 36B10 cells as assessed using the clonogenic cell survival assay. Incubating the cells with 45 ,UM GLA reduced their survival to 55% (P < 0.01) of the controls, which received no fatty acid supplement ( Figure SA) . GLA supplementation (45 ,UM) also significantly enhanced the radiation response of the 36B10 cells (P < 0.01; Figure 5B ). As previously published (Vartak et Bars indicate values obtained from one experiment with n = 5 (mean + s.e.). *P < 0.05 and **P < 0.01; significantly different from respective controls Figure 6 shows the effect of GLA ( Figure 6A ) and GLA plus 7.5-Gy radiation ( Figure 6B ) on the survival of 'normal' rat astrocytes compared with the rat astrocytoma cells, assessed using the fluorescent dye calcein AM. Consistent with the clonogenic assay, supplementation of 36B10 cells with 45 ,UM GLA alone reduced their survival to 65 ± 1.59% of the controls (P < 0.01; Figure 6A ). However, GLA had no effect on the viability of the astrocytes. Similarly, GLA at 45 ,UM enhanced the radiation response of the astrocytoma cells but not that of the astrocytes ( Figure 6A and B) . In contrast, supplementation of the neoplastic astrocytoma cells or astrocytes with LA did not affect their survival or radiation response as assessed by the fluorescent dye assay (data not shown).
Effect of trolox and GLA on survival and radiation response of astrocytoma cells Figure 7A shows the effects of trolox on the survival of 36B10 cells supplemented with GLA. Incubation of the cells with 50 or 100 gM trolox alone did not affect their survival; as previously noted (Vartak et al, 1997) , GLA (45 gM) supplementation reduced survival to 55 ± 8.8% of control values (P < 0.01). However, when the cells were supplemented with trolox in addition to the GLA, the cytotoxic effect of GLA was completely blocked. Similarly, British Journal of Cancer (1998) were irradiated with 0-to IO-Gy y-radiation. "Significantly different from controls; P < 0.01 addition of trolox along with GLA led to a complete inhibition of the enhancement of radiation response observed in GLAsupplemented cells ( Figure 7B ).
8-Isoprostane levels of 36B1 0 cells supplemented with GLA As the protective effect of trolox suggested that GLA might act through the production of oxidative products, we determined whether 8-isoprostane production increased in the supplemented cells. Figure 8 Effect of cyclo-oxygenase and lipoxygenase inhibitors on the radiation response of GLA-supplemented 36B10 cells In order to investigate whether prostanoid and/or leukotriene synthesis is involved in the cytotoxic effect of GLA and its enhancement of the radiation response in the neoplastic cells, the cyclo-oxygenase inhibitors ibuprofen and indomethacin and the lipoxygenase inhibitor NDGA were tested. Ibuprofen alone had no effect on the survival of the astrocytoma cells and addition of ibuprofen plus GLA did not affect GLA cytotoxicity ( Figure 9A ). However, incubating the cells with ibuprofen along with GLA completely blocked the GLA-induced enhancement of radiation response of 36B 10 cells ( Figure 9B ). Similar results were obtained with 2.5-10 gM indomethacin (data not shown).
British Joumal of Cancer (1998) Figure 9 Cyclo-oxygenase inhibitor prevents the GLA enhancement of the radiation response but not GLA-mediated cytotoxicity. A shows the effect of 45 gM GLA and 50-100 gM ibuprofen on the survival of 36B10 cells. Cells were supplemented with 50 gM (D) or 100 gM (2) ibuprofen alone, 45 gM GLA alone (PI), GLA and 50 gM ibuprofen (E1) or GLA and 100 gM ibuprofen (-) throughout the duration of the experiment (7 days). Control cultures (O) received no supplement. Values represent mean ± s.e. obtained from two experiments (n = 6). B shows the effect of GLA and ibuprofen on the radiation response of 36B10 cells. Cells supplemented with 50 (0) or 100 gM (A) ibuprofen alone, 45 gM GLA alone (A), GLA and 50 gM ibuprofen (O) or GLA and 100 gM ibuprofen (-) for 24 h were irradiated with 0-to 1 O-Gy yradiation. Cells were continued on supplemented media throughout the experiment. Control cultures (0) received no supplement. Values represent mean ± s.e. obtained from two experiments (n = 6). "Significantly different from controls; P< 0.01
The lipoxygenase inhibitor NDGA, at concentrations of 1-5 tM, did not affect the survival of the astrocytoma cells (data not shown). Further, incubation of the astrocytoma cells with GLA and NDGA did not affect GLA cytotoxicity or the GLA-induced increase in radiation sensitivity (data not shown).
DISCUSSION
The present results show that the overall pattem of distribution and metabolism of GLA and LA by 36B10 malignant rat astrocytoma cells differs little from that of the astrocytes. However, GLA is cytotoxic to the astrocytoma cells but not to the 'normal' astrocytes. In contrast, the precursor of GLA, LA, is not cytotoxic to either 36B10 cells or astrocytes. The increase in 8-isoprostane formation after GLA supplementation and the protective effect of trolox in the astrocytoma cells suggest that the cytotoxic action of GLA alone and the GLA-mediated increase in radiation-induced cytotoxicity is the result of increased lipid peroxidation and/or free radical generation. However, the ability of the cyclo-oxygenase inhibitors ibuprofen and indomethacin to block the GLA-mediated increase in astrocytoma cell radiosensitivity suggests that, in addition to the increased oxidative stress, this effect may involve increased prostanoid synthesis.
Changes in fatty acid composition as a result of alterations in the type of fatty acid available have been reported in vivo and in vitro (Burns and Spector, 1987) . Indeed, we have previously demonstrated marked changes in the fatty acid profiles of 36B 10 cells supplemented with GLA (Vartak et al, 1997) . We have tested the ability of the cells to use this fatty acid in the present study. Our results show that both neoplastic astrocytoma cells and 'normal' astrocytes are able to incorporate GLA and LA. The amount of GLA or LA incorporated into the astrocytes was greater than the 36B10 cells. However, we have observed that GLA was toxic to the 36B10 cells; astrocytes were unaffected. Thus, the selectively cytotoxic effect of GLA cannot be explained based on differences in uptake of GLA by the cells.
A difference in the distribution of the fatty acids into the various phospholipid classes was also observed for the two cell types. All GLA or LA supplied to the astrocytoma cells was first incorporated into the PC fraction, with a gradual shift to PE over time ( Figure 2A ). However, this shift was much more dramatic in the GLA-supplemented astrocytoma cells than when they were incubated in LA-enriched medium. Studies conducted on the distribution of the different phospholipid classes in various mammalian cell membranes show that the outer leaflet of the lipid bilayer predominantly consists of PC while the majority of the PE is confined to the inner leaflet (Cullis and Hope, 1991) . Thus, the shift of radiolabelled fatty acid from PC to PE observed in our study may simply reflect a redistribution of the newly incorporated fatty acids from the outer to the inner leaflet of the cell membrane.
The shift of radioactivity from the PC to the PE fraction may also be due to increased amounts of AA in the cells. Unsaturated fatty acids are incorporated preferentially with regard to individual phospholipid classes. While OA and LA are found primarily in the PC fraction, AA is transferred to both PE and PI. Several groups have reported a redistribution of AA from PC to PE when AA was provided to cells (Aeberhard et al, 1984; Goppelt et al, 1985) . We observed that the 36B 10 cells rapidly converted the GLA supplied to AA; the transfer of radioactivity from the PC to the PE fraction may reflect this conversion of GLA to AA. In addition, the relatively slower shift of radioactivity from PC to PE in LA-supplemented cells observed in the present study might be because of the slower conversion of LA to AA by the astrocytoma. The astrocytes, however, incorporated most of the fatty acid supplied into the PC fraction with little shift to PE over the time course studied ( Figure 2B ). While the exact reason for this remains unclear, the results do suggest that the two cell types incorporate the fatty acid supplied into different membrane compartments.
Our results show that GLA is selectively toxic to the tumour cells, whereas it has no deleterious effect on astrocyte survival. In contrast, LA has no toxic effect on either of these cell populations. Studies on several different neoplastic cell types also indicate that GLA has a greater cytotoxic effect than LA (Fujiwara et al, 1986; Begin et al, 1998; Connolly, 1991; Madhavi and Das, 1994) . Our results suggest that the difference in the cytotoxicity of GLA and LA might be due, in part, to differences in their metabolism by the astrocytoma cells. While the 36B 10 cells could rapidly elongate and desaturate GLA to DGLA and AA ( Figure 3A ), these cells British Journal of Cancer (1998) 77(10), [1612] [1613] [1614] [1615] [1616] [1617] [1618] [1619] [1620] showed a rapid uptake of LA but a relatively slow conversion of this fatty acid to DGLA and AA ( Figure 4A) . The difference in the amount of long-chain PUFAs, such as AA, present in the GLA-or LA-enriched cells might explain the difference in cytotoxic effect of the two fatty acids. However, our unpublished data on the effect of AA on survival of astrocytoma cells shows that this fatty acid does not affect the survival of these cells. Thus, the cytotoxic effect of GLA and the lack thereof using LA cannot be explained by the rapid conversion of GLA to AA.
LA is converted to GLA by the action of a A-6-desaturase enzyme (Dunbar and Bailey, 1975) . Although a complete loss of A-6-desaturase in several tumour cells has been reported (Dunbar and Bailey, 1975) , some conversion of LA to its longer-chain, more unsaturated metabolites was observed in the 36B10 astrocytoma cells. Recent studies on PUFA metabolism have shown that there is considerable variation in the ability of normal and neoplastic cells to elongate and desaturate PUFAs (Grammatikos et al, 1994) . The ability of the astrocytoma cells to metabolize LA, as observed in this study (Figure 4A) , indicates that some A-6-desaturase activity is present in these tumour cells. Our results are thus in agreement with the findings of others that indicate the presence of A-6-desaturase activity in cultured neuroblastoma cells and other brain tumours (Robert et al, 1978; Grammatikos et al, 1994) .
The selective cytotoxic effect of GLA may also be due to the reduced ability of the neoplastic astrocytoma cells to protect themselves against lipid peroxidation and/or free radical generation resulting from the increased PUFA content. Increased 8-isoprostane levels in the 36B10 cells after GLA supplementation do indicate increased oxidative stress in these cells. Antioxidant enzymes, such as superoxide dismutase (SOD), catalase and glutathione peroxidase, are the cells' primary mechanisms for scavenging free radicals. Studies have shown decreased activities of these enzymes in many tumour cells (Tisdale and Mahmoud, 1983; Oberley et al, 1989) . Preliminary results in our laboratory show that the manganese (Mn) and copper-zinc (CuZn) SOD levels in 36B10 cells are significantly lower than those of astrocytes, and supplementation of 36B 10 cells with GLA failed to alter the SOD levels in these neoplastic cells (unpublished data).
Our findings that 'normal' astrocytes were unaffected by GLA suggests that they are able to deal with the increased oxidative stress resulting from PUFA supplementation. The mechanism might involve a PUFA-mediated increase in antioxidant enzyme activity. We have observed that GLA supplementation increases the activity of MnSOD in rat astrocytes (Gimun et al, 1996) . Moreover, in vivo results also show an increase in expression and activity of these antioxidant enzymes in normal mouse liver (Venkatraman et al, 1994) and rat heart (Phylactos et al, 1994) .
Thus, the reduced ability of the astrocytoma cells to scavenge free radicals might account for the cytotoxicity of GLA in these cells. Free radical generation in these PUFA-enriched 36B10 cells may be further increased after irradiation. Indeed, providing 36B10 cells with trolox not only blocked the cytotoxic effect of GLA, but also blocked the GLA-mediated increase in glioma cell radiosensitivity. Thus, our results support the hypothesis that the cytotoxic effect of GLA in tumour cells is, at least in part, the result of increased generation of free radicals and lipid peroxidation (Begin et al, 1988; Ells et al, 1996) . LA supplementation did not affect the survival of 36B 10 cells and astrocytes. We observed that the 8-isoprostane level of astrocytoma cells and astrocytes supplemented with LA did not differ from the unsupplemented controls, indicating that there was no difference in free radical formation between LA-enriched cells and controls. This may explain the lack of cytotoxic effect of LA on the astrocytoma cells.
Studies indicate that eicosanoid and leukotriene synthesis play an important role in tumour cell proliferation (Earashi et al, 1995; Damtew and Spagnuolo, 1997) . On the other hand, several investigators have reported that prostanoid and leukotriene synthesis do not play a role in PUFA-induced tumour cell cytotoxicity (Begin et al, 1985; Das, 1991) . Thus, there appear to be contradictory views on the role of prostanoid and leukotriene synthesis in the cytotoxic effect of PUFAs. The inability of the cyclo-oxygenase inhibitors ibuprofen and indomethacin to block the cytotoxic effect of GLA alone, as observed in the present study, supports the view that prostanoid and leukotriene synthesis are not involved in GLA cytotoxicity. However, both ibuprofen and indomethacin blocked the enhanced radiation response of 36B 10 cells supplemented with GLA. Thus, while the cytotoxic effect of GLA alone is likely to result from increased oxidative stress, the augmentation of radiation response of GLA-supplemented astrocytoma cells might also involve an increase in prostanoid synthesis. However, the exact mechanism(s) by which prostanoids affect GLA-mediated increase in radiation sensitivity is not known and needs to be investigated.
In summary, the present results indicate that GLA is selectively cytotoxic to 36B 10 malignant rat astrocytoma cells; 'normal' rat astrocytes are not affected. GLA also selectively increases the radiation response of the neoplastic astrocytoma cells. Malignant gliomas are extremely radioresistant and difficult to treat (Laramore et al, 1989; Imperato et al, 1991; Phuphanich et al, 1993) . Moreover, damage to surrounding normal tissues is a major dose-limiting factor in the treatment of these tumours (Sheline et al, 1980; Leibel et al, 1989) . The use of GLA as a therapeutic adjunct may provide benefit in the treatment of this type of malignant brain tumour with radiation.
